Homepage
Medication Guide
Precautions for Administration of Teneligliptin Hydrobromide/Canagliflozin Combination Tablets (Canalia)
Teneligliptin Hydrobromide/Canagliflozin Combination Tablets (Canalia) is a fixed-dose combination preparation of a DPP-4 inhibitor and an SGLT2 inhibitor developed by Mitsubishi Tanabe Pharma (Japan)...
523
Friday, November 14th, 2025, 10:14
Indications for Teneligliptin Hydrobromide/Canagliflozin Combination Tablets (Canalia)
Teneligliptin Hydrobromide/Canagliflozin Combination Tablets (Canalia) is a dual-mechanism antidiabetic fixed-dose combination preparation developed by Mitsubishi Tanabe Pharma (Japan) and co-promoted...
513
Friday, November 14th, 2025, 10:11
How to Purchase Teneligliptin Hydrobromide/Canagliflozin Combination Tablets (Canalia)
Teneligliptin Hydrobromide/Canagliflozin Combination Tablets (Canalia) is a dual-target (DPP-4 and SGLT2) fixed-dose combination preparation developed by Mitsubishi Tanabe Pharma (Japan). It demonstra...
522
Friday, November 14th, 2025, 10:03
Indications for Vigabatrin (Sabril)
Vigabatrin (Sabril) is an antiepileptic drug commonly used to treat specific types of seizures, particularly in cases where other treatments have shown poor efficacy. Understanding its indications, do...
514
Friday, November 14th, 2025, 09:58
How to Use Repotrectinib (Augtyro)
Repotrectinib (Augtyro) is a novel kinase inhibitor that received its first approval in the United States in 2023. This medication is primarily indicated for the treatment of ROS1-positive non-small c...
514
Friday, November 14th, 2025, 09:52
Indications for Repotrectinib (Augtyro)
Repotrectinib (Augtyro) is an innovative kinase inhibitor that received its first approval from the U.S. Food and Drug Administration (FDA) in 2023. As a next-generation targeted therapy, repotrectini...
516
Friday, November 14th, 2025, 09:48
How to Purchase Repotrectinib (Augtyro)
Repotrectinib (Augtyro) is a next-generation kinase inhibitor and an important targeted medication for the treatment of ROS1-positive non-small cell lung cancer (NSCLC) and NTRK gene fusion-positive s...
510
Thursday, November 13th, 2025, 13:21
What Are the Side Effects of Rasagiline (Azilect)?
Rasagiline (Azilect) is a selective and irreversible monoamine oxidase type B (MAO-B) inhibitor, approved for the treatment of Parkinson's disease. While this medication effectively improves motor...
508
Thursday, November 13th, 2025, 13:16
Precautions for Using Rasagiline (Azilect)
Rasagiline (Azilect) is one of the important medications currently used for the treatment of Parkinson's disease. As a monoamine oxidase (MAO) inhibitor, this drug carries specific risks such as h...
513
Thursday, November 13th, 2025, 13:09
How to Use Rasagiline (Azilect)
Rasagiline (Azilect) is a selective and irreversible monoamine oxidase type B (MAO-B) inhibitor, which was first approved for marketing in the United States in 2006. This medication is indicated for t...
507
Thursday, November 13th, 2025, 11:49
71 / 221
2204 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved